Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study

Internal and Emergency Medicine

Volumn 10, Issue 1, 2015, Pages 25-31

  Cicero, Arrigo Francesco Giuseppe ^a,c   Desideri, Giovambattista ^b   Grossi, Giulia ^a   Urso, Riccardo ^a   Rosticci, Martina ^a   D’Addato, Sergio ^a   Borghi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cognitive function; Epidemiology; MMSE; Risk factors; Serum uric acid

Indexed keywords

URIC ACID;

AGED; BLOOD; CAROTID ARTERY DISEASE; COGNITION; COHORT ANALYSIS; COMPLICATION; FEMALE; HUMAN; ITALY; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PHYSIOLOGY;

AGED; CAROTID ARTERY DISEASES; COGNITION; COHORT STUDIES; FEMALE; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; URIC ACID;

EID: 84938528658     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-014-1098-z     Document Type: Article

References (50)

1. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007) How common are the “common” neurologic disorders? Neurology 68:326–337
2. Flirski M, Sobow T (2005) Biochemical markers and risk factors of Alzheimer’s disease. Curr Alzheimer Res 2:47–64. doi:10.2174/1567205052772704
3. Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH (2007) How and when environmental agents and dietary factors affect the course of Alzheimer’s disease: the ‘LEARn’ model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res 4:219–228
4. Breteler MMB (2000) Vascular risk factors for Alzheimer disease. Neurobiol Aging 21:153–160
5. Christen Y (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr 71:621S–629S
6. Zhu X, Raina AK, Perry G, Smith MA (2004) Alzheimer’s disease: the two-hit hypothesis. Lancet Neurol 3:219–226
7. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Shamim W, Kemp M, Segal R, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107:1991–1997. doi:10.1161/01.CIR.0000065637.10517.A0
8. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27:1174–1181. doi:10.1093/eurheartj/ehi879
9. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R (2002) Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure. Circulation 105:2619–2624. doi:10.1161/01.CIR.0000017502.58595.ED
10. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J (2005) A unifying pathway for essential hypertension. Am J Hypertens 18:431–440
11. Ford ES, Li C, Cook S, Choi HK (2007) Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115:2526–2532
12. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190. doi:10.1161/01.HYP.0000069700.62727.C5
13. Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811–1821
14. Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, Gossios T, Krikis N, Moschou I, Xochellis M, Athyros VG (2007) Serum uric acid as an independent predictor of early death after acute stroke. Circ J 71:1120–1127
15. Schretlen DJ, Inscore AB, Jinnah HA, Rao V, Gordon B, Pearlson GD (2007) Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 21(1):136–140
16. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, Jinnah HA (2007) Serum uric acid and brain ischemia in normal elderly adults. Neurology 69(14):1418–1423
17. Vannorsdall TD, Jinnah HA, Gordon B, Kraut M, Schretlen DJ (2008) Cerebral ischemia mediates the effect of serum uric acid on cognitive function. Stroke 39:3418–3420
18. Ruggiero C, Cherubini A, Lauretani B et al (2009) Uric acid and dementia in community-dwelling older persons. Dement Geriatr Cogn Disord 27:382–389
19. Afsar B, Elsurer R, Covic A, Johnson RJ, Kanbay M (2011) Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol 34:49–54
20. Cicero AFG, Dormi A, D’Addato S, Borghi C, Brisighella Heart Study Staff (2011) From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study. Clin Lipidol 6:269–276
21. Cicero AF, D’Addato S, Santi F, Ferroni A, Borghi C, Brisighella Heart Study (2012) Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. J Cardiovasc Med 13:559–564
22. Cicero AF, D’Addato S, Veronesi M, Rosticci M, Santi F, Dormi A, Borghi C, Brisighella Heart Study Group (2012) Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study. J Hypertens 30:492–496. doi:10.1097/HJH.0b013e32834f6b11
23. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
24. Bonin-Guillaume S, Clément JP, Chassain AP, Léger JM (1995) Psychometric evaluation of depression in the elderly subject: which instruments? What are the future perspectives? Encephale 21:25–34
25. Simera I, Moher D, Hoey J, Schulz KF, Altman DG (2010) A catalogue of reporting guidelines for health research. Eur J Clin Invest 40:35–53
26. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
27. Crum RM, Anthony JC, Bassett SS, Folstein MF (1993) Population-based norms for the mini-mental state examination by age and educational level. JAMA 269:2386–2391
28. O’Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA (2008) Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol 65:963–967. doi:10.1001/archneur.65.7.963
29. Euser SM, Hofman A, Westendorp RG, Breteler MM (2009) Serum uric acid and cognitive function and dementia. Brain 132(Pt 2):377–382
30. Álvarez-Lario B, Macarrón-Vicente J (2010) Uric acid and evolution. Rheumatology 49:2010–2015
31. Wu Y, Zhang D, Pang Z, Jiang W, Wang S, Tan Q (2013) Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50–74 years. Geriatr Gerontol Int 13:672–677
32. Irizarry MC, Raman R, Schwarzschild MA, Becerra LM, Thomas RG, Peterson RC, Ascherio A, Aisen PS (2009) Plasma urate and progression of mild cognitive impairment. Neurodegener Dis 6(1–2):23–28. doi:10.1159/000170883
33. Kim TS, Pae CU, Yoon SJ, Jang WY, Lee NJ, Kim JJ, Lee SJ, Lee C, Paik IH, Lee CU (2006) Decreased plasma antioxidants in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 21:344–348. doi:10.1002/gps.1469
34. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging 24:915–919. doi:10.1016/S0197-4580(03)00031-9
35. Polidori MC, Mattioli P, Aldred S, Cecchetti R, Stahl W, Griffiths H, Senin U, Sies H, Mecocci P (2004) Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord 18:265–270. doi:10.1159/000080027
36. Khanna D, Khanna PP, Fizgerald JD, American College of Rheumatology et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic non pharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64:1447–1461
37. Yu MA, Sánchez-Lozada LG, Johnson RJ, Kang DH (2010) Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 28:1234–1242
38. Vannorsdall TD, Jinnah HA, Gordon B, Kraut M, Schretlen DJ (2008) Cerebral ischemia mediates the effect of serum uric acid on cognitive function. Stroke 39(12):3418–3420
39. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36:1072–1078
40. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, Saito A, Sone H (2009) Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32:1737–1742. doi:10.2337/dc09-0288
41. Gorelick PB, Scuteri A, Black SE, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. et al (2011) Vascular contributions to cognitive impairment and dementia. A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:2672–2713
42. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM (2006) Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37:1503–1507
43. Hozawa A, Folsom AR, Ibrahim H, Nieto FJ, Rosamond WD, Shahar E (2006) Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis 187:401–407
44. Verhaaren BF, Vernooij MW, Dehghan A, Vrooman HA, de Boer R, Hofman A, Witteman JC, Niessen WJ, Breteler MM, van der Lugt A, Ikram MA (2013) The relation of uric acid to brain atrophy and cognition: the Rotterdam Scan Study. Neuroepidemiology 41:29–34. doi:10.1159/000346606
45. Scuteri A, Nilsson PM, Tzourio C, Redon J, Laurent S (2011) Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens 29:1469–1477
46. Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF (2010) Uric acid as a CNS antioxidant. J Alzheimers Dis 19:1331–1336
47. Shigemori K, Ohgi S, Okuyama E, Shimura T, Schneider E (2010) The factorial structure of the mini-mental state examination (MMSE) in Japanese dementia patients. BMC Geriatr 10:36. doi:10.1186/1471-2318-10-36
48. Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. JAGS 40:922–935
49. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R (2004) Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 31:1582–1587
50. Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G (2013) Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis 72:694–700. doi:10.1136/annrheumdis-2011-201254